Trevena Inc. [TRVN] is -28.76% lower this YTD. Is it still time to buy?


Trevena Inc. [NASDAQ: TRVN] gained 6.63% or 0.02 points to close at $0.41 with a heavy trading volume of 3040229 shares. The company report on May 18, 2022 that Trevena to Present at the H.C. Wainwright Global Investment Conference.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Carrie Bourdow, President & CEO and Barry Shin, CFO, will be participating in the H.C. Wainwright Global Investment Conference being held May 23 – 26, 2022.

It opened the trading session at $0.3913, the shares rose to $0.44 and dropped to $0.385, the range by which the price of stock traded the whole day. The daily chart for TRVN points out that the company has recorded -38.97% loss over the past six months. However, it is still -127.78% lower than its most recent low trading price.

If we look at the average trading volume of 1.60M shares, TRVN reached to a volume of 3040229 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Trevena Inc. [TRVN]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TRVN shares is $3.17 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TRVN stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Oppenheimer have made an estimate for Trevena Inc. shares, keeping their opinion on the stock as Perform, with their previous recommendation back on March 15, 2021. While these analysts kept the previous recommendation, Guggenheim raised their target price to Buy. The new note on the price target was released on September 14, 2020, representing the official price target for Trevena Inc. stock. Previously, the target price had yet another raise to $5, while Cantor Fitzgerald analysts kept a Overweight rating on TRVN stock.

The Average True Range (ATR) for Trevena Inc. is set at 0.05, with the Price to Sales ratio for TRVN stock in the period of the last 12 months amounting to 178.36. The Price to Book ratio for the last quarter was 1.38, with the Price to Cash per share for the same quarter was set at 0.28.

Trading performance analysis for TRVN stock

Trevena Inc. [TRVN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 24.44. With this latest performance, TRVN shares gained by 64.29% in over the last four-week period, additionally sinking by -38.97% over the last 6 months – not to mention a drop of -79.04% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TRVN stock in for the last two-week period is set at 66.09, with the RSI for the last a single of trading hit 74.67, and the three-weeks RSI is set at 60.01 for Trevena Inc. [TRVN]. The present Moving Average for the last 50 days of trading for this stock 0.3383, while it was recorded at 0.3808 for the last single week of trading, and 0.6876 for the last 200 days.

Trevena Inc. [TRVN]: A deeper dive into fundamental analysis

Trevena Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.80 and a Current Ratio set at 6.10.

An analysis of insider ownership at Trevena Inc. [TRVN]

There are presently around $14 million, or 20.30% of TRVN stock, in the hands of institutional investors. The top three institutional holders of TRVN stocks are: BLACKROCK INC. with ownership of 10,893,566, which is approximately -2.207% of the company’s market cap and around 2.80% of the total institutional ownership; VANGUARD GROUP INC, holding 7,076,218 shares of the stock with an approximate value of $2.94 million in TRVN stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $1.35 million in TRVN stock with ownership of nearly 8.118% of the company’s market capitalization.

Positions in Trevena Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 23 institutional holders increased their position in Trevena Inc. [NASDAQ:TRVN] by around 1,979,755 shares. Additionally, 46 investors decreased positions by around 4,243,150 shares, while 25 investors held positions by with 27,002,739 shares. The mentioned changes placed institutional holdings at 33,225,644 shares, according to the latest SEC report filing. TRVN stock had 7 new institutional investments in for a total of 1,000,750 shares, while 11 institutional investors sold positions of 477,580 shares during the same period.